Immunic, Inc. (IMUX): Price and Financial Metrics

$13.37 0.50 (-3.60%)
Quote Time: Jul 7 4:00pm

Immunic, Inc. (IMUX)

Today's Latest Price: $13.37 USD

0.50 (-3.60%)

Updated Jul 7 4:00pm

Add IMUX to Watchlist
Sign Up

Overall POWR Rating

Sign Up to See Ratings...FREE!

POWR Components:

Trade Grade Buy & Hold Grade Peer Grade Industry Rank

Industry Rank:

Ranked of 336 in Biotech

See all "A" rated Strong Buy stocks

IMUX Daily Price Range

IMUX 52-Week Price Range

IMUX Stock Price Chart Technical Analysis Charts

IMUX Price/Volume Stats

Current price	$13.37	52-week high	$19.05
Prev. close	$13.87	52-week low	$4.19
Day low	$12.79	Volume	387,135
Day high	$14.10	Avg. volume	179,350
50-day MA	$11.31	Dividend yield	N/A
200-day MA	$9.03	Market Cap	200.12M

Immunic, Inc. (IMUX) Company Bio

Immunic Inc. (formerly Vital Therapies) is a biotherapeutic company developing a cell-based therapy targeting the treatment of liver failure. The company was founded in 2003 and is based in San Diego, California.

Event/Time	News Detail
Loading, please wait...

3 “Strong Buy” Micro-Cap Stocks That Offer Attractive Returns

If you are looking to hit a home run in the stock market, the NASDAQ Composite is a good place to start. The index is home to surging technology, internet, and biotech stocks. Despite the adverse effects from COVID-19, the index is up 25% over the past year, and recently hit a new all-time high. Now comes the hard part. How are investors supposed to determine which stocks are poised to take off? Will the current winners continue climbing, or will new high-flyers emerge? Finding the next big one is challenging to say the least. On top of this, there are numerous and sometimes conflicting investing strategies to consider. Bearing this in mind, Wall Street analysts can provide some inspiration. The experts possess extensive knowledge about the stocks they cover, and offer insights on com...

Yahoo | July 5, 2020

ImmunoGen (IMGN) Investor Presentation - Slideshow

The following slide deck was published by Immunic, Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | June 24, 2020

Immunic joins Russell 3000 Index

Immunic (IMUX) is set to join the broad-market Russell 3000 Index, effective after the US market opens on June 29....

Seeking Alpha | June 22, 2020

Immunic, Inc. to Join Russell 3000® Index

Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today announced that the company is set to join the broad-market Russell 3000® Index at the conclusion of the 2020 Russell indexes annual reconstitution, effective after the US market opens on June 29, according to a final list of additions accessed on June 19.

Yahoo | June 22, 2020

Immunic, Inc. Announces First Patients Dosed in its Phase 2, CALVID-1 Clinical Trial of IMU-838 in COVID-19

Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today announced dosing of the first patients in its phase 2, CALVID-1 clinical trial of IMU-838, the company's selective oral DHODH inhibitor, in coronavirus disease 2019 (COVID-19), at several sites in different European countries. Patients will be enrolled at 10 to 35 centers in Germany, the United States and a half dozen European countries.

Yahoo | June 15, 2020

1-mo	-2.90%
3-mo	105.69%
6-mo	45.80%
1-year	24.26%
3-year	-88.47%
5-year	-98.71%

YTD	37.84%
2019	27.63%
2018	-96.81%
2017	36.78%
2016	-62.24%
2015	-53.79%

Immunic, Inc. (IMUX): Price and Financial Metrics

Immunic, Inc. (IMUX)

Overall POWR Rating

POWR Components:

Industry Rank:

See all "A" rated Strong Buy stocks

IMUX Stock Price Chart Technical Analysis Charts

IMUX Price/Volume Stats

Immunic, Inc. (IMUX) Company Bio

Top Stories View All

• 2 Gun Stocks for the Second Half of 2020

• Top 5 Large Cap Dividend Stocks for July 7, 2020

• 3 Meal Delivery Stocks to Buy Now

• 3 Cheap Commodity Stocks With Major Upside

• 3 Energy Stocks to Avoid for the Remainder of 2020

IMUX Latest News Stream

IMUX Latest Social Stream

Latest IMUX News From Around the Web

3 “Strong Buy” Micro-Cap Stocks That Offer Attractive Returns

ImmunoGen (IMGN) Investor Presentation - Slideshow

Immunic joins Russell 3000 Index

Immunic, Inc. to Join Russell 3000® Index

Immunic, Inc. Announces First Patients Dosed in its Phase 2, CALVID-1 Clinical Trial of IMU-838 in COVID-19

IMUX Price Returns

Get Free Updates